DS
Therapeutic Areas
Carisma Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CT-0508 | HER2-Overexpressing Solid Tumors | Phase 1 |
| CT-0525 | HER2-Positive Solid Tumors | Preclinical |
| In Vivo CAR-M | Undisclosed Oncology Targets | Discovery |
| CT-1119 | GPC3+ Solid Tumors | Discovery/Preclinical |
| CT-2401 | Liver Fibrosis | Discovery/Preclinical |
| Autoimmune Disease Program | Autoimmune Disease | Discovery |